Vor Biopharma Inc. (VOR) Ownership
VOR ownership summary
as of October 18, 2026- Institutions
- 86.8% of shares outstanding
- Insiders
- 9.26% of shares outstanding
- Shares outstanding
- 54.2M
- Float
- 37.2M shares available to trade
- Short interest
- 15.54% 7.8M shares short
- Days to cover
- 6.11 short interest down 1.1% vs prior month
- Institutions 86.82%
- Insiders 9.26%
- Other investors 3.92%
VOR top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLC | 9.59% | 5.7M | $102.3M | — | June 30, 2026 |
| 2 | FMR Inc | 8.34% | 4.9M | $88.9M | +3.4M (+220.3%) | June 30, 2026 |
| 3 | FCPM III SERVICES BV | 6.96% | 4.1M | $74.2M | — | June 30, 2026 |
| 4 | BlackRock Inc | 5.86% | 3.5M | $62.5M | +2.7M (+336.4%) | June 30, 2026 |
| 5 | VR Adviser, LLC | 5.14% | 3.0M | $54.8M | — | June 30, 2026 |
| 6 | State Street Corp | 4.42% | 2.6M | $47.2M | +1.5M (+133.9%) | June 30, 2026 |
| 7 | Frazier Life Sciences Management, L.P. | 4.30% | 2.5M | $45.9M | — | June 30, 2026 |
| 8 | RA Capital Management, LLC | 4.06% | 2.4M | $43.3M | −3.0M (−55.6%) | June 30, 2026 |
| 9 | Vanguard Capital Management, LLC | 3.52% | 2.1M | $37.6M | +651,048 (+45.4%) | June 30, 2026 |
| 10 | Caligan Partners LP | 3.25% | 1.9M | $34.7M | — | June 30, 2026 |
| 11 | Paradigm Biocapital Advisors LP | 2.96% | 1.8M | $31.6M | — | June 30, 2026 |
| 12 | Great Point Partners LLC | 2.87% | 1.7M | $30.7M | −50,000 (−2.9%) | June 30, 2026 |
| 13 | Nantahala Capital Management, LLC | 2.86% | 1.7M | $30.5M | +1.7M (0.0%) | June 30, 2026 |
| 14 | Geode Capital Management, LLC | 1.80% | 1.1M | $19.2M | +719,896 (+210.1%) | June 30, 2026 |
| 15 | NEXTBio Capital Management LP | 1.50% | 889K | $16.0M | −110,803 (−11.1%) | June 30, 2026 |
| 16 | ADAR1 Capital Management LLC | 1.15% | 681K | $12.3M | +680,626 (0.0%) | June 30, 2026 |
| 17 | Logos Global Management LP | 1.10% | 650K | $11.7M | −100,000 (−13.3%) | June 30, 2026 |
| 18 | Rosalind Advisors, Inc. | 1.10% | 649K | $11.7M | −51,400 (−7.3%) | June 30, 2026 |
| 19 | NAN FUNG TRINITY (HK) Ltd | 1.09% | 647K | $11.7M | +646,550 (0.0%) | June 30, 2026 |
| 20 | BRAIDWELL LP | 0.97% | 573K | $10.3M | +106,330 (+22.8%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 12.1M shares and 5 cut 3.3M.
VOR top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.62% | 1.6M | $28.0M | — | August 31, 2026 |
| 2 | Fidelity Select Biotechnology | 2.37% | 1.4M | $25.2M | — | August 31, 2026 |
| 3 | Fidelity Small Cap Growth | 2.15% | 1.3M | $22.9M | — | July 31, 2026 |
| 4 | State Street® SPDR® S&P® Biotech ETF | 1.86% | 1.1M | $19.8M | −21,000 (−1.9%) | September 30, 2026 |
| 5 | iShares Russell 2000 ETF | 1.68% | 996K | $18.0M | −11,456 (−1.1%) | September 30, 2026 |
| 6 | Fidelity Small Cap Growth K6 | 1.10% | 651K | $11.7M | — | July 31, 2026 |
| 7 | Fidelity Stock Selector Small Cap | 1.00% | 590K | $10.6M | — | July 31, 2026 |
| 8 | Fidelity Small Cap Index | 0.75% | 446K | $8.0M | +3,695 (+0.8%) | July 31, 2026 |
| 9 | Strategic Advisers Fidelity US TtlStk | 0.73% | 435K | $7.8M | +29,913 (+7.4%) | August 31, 2026 |
| 10 | Fidelity Series Small Cap Opps | 0.68% | 402K | $7.3M | — | July 31, 2026 |
| 11 | Fidelity Small Cap Discovery | 0.59% | 348K | $6.3M | +312,860 (+893.9%) | July 31, 2026 |
| 12 | Fidelity Advisor Biotechnology I | 0.58% | 344K | $6.2M | — | August 31, 2026 |
| 13 | Fidelity Series Small Cap Discovery | 0.50% | 298K | $5.4M | +267,400 (+873.9%) | July 31, 2026 |
| 14 | Franklin Biotechnology Discv A(acc)USD | 0.47% | 277K | $5.0M | — | August 31, 2026 |
| 15 | iShares Russell 2000 Growth ETF | 0.42% | 249K | $4.5M | −315 (−0.1%) | September 30, 2026 |
| 16 | Vanguard Russell 2000 ETF | 0.40% | 234K | $4.2M | +5,552 (+2.4%) | August 31, 2026 |
| 17 | Fidelity Extended Market Index | 0.36% | 212K | $3.8M | −3,560 (−1.7%) | August 31, 2026 |
| 18 | Schwab US Small-Cap ETF™ | 0.34% | 200K | $3.6M | +135 (+0.1%) | September 30, 2026 |
| 19 | Fidelity Enhanced Small Cap Core ETF | 0.31% | 186K | $3.3M | +387 (+0.2%) | September 30, 2026 |
| 20 | Bridge Builder Small/Mid Cap Value | 0.29% | 171K | $3.1M | +171,289 (0.0%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
VOR insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | Ra Capital Management, L.P. | Sell | $15.77 | 165,150 | $2.6M |
| 2026-04-20 | Ra Capital Management, L.P. | Sell | $15.77 | 171,963 | $2.7M |
| 2026-04-17 | Ra Capital Management, L.P. | Sell | $16.28 | 458,411 | $7.5M |
| 2026-04-15 | Ra Capital Management, L.P. | Sell | $16.01 | 53,644 | $858,840 |
| 2026-04-14 | Ra Capital Management, L.P. | Sell | $15.97 | 153,735 | $2.5M |
| 2026-04-13 | Ra Capital Management, L.P. | Sell | $16.15 | 530,610 | $8.6M |
| 2026-04-10 | Ra Capital Management, L.P. | Sell | $15.75 | 828 | $13,041 |
| 2026-04-09 | Ra Capital Management, L.P. | Sell | $16.59 | 135,201 | $2.2M |
| 2026-04-08 | Ra Capital Management, L.P. | Sell | $16.48 | 484,104 | $8.0M |
| 2026-04-06 | Ra Capital Management, L.P. | Sell | $16.59 | 589,257 | $9.8M |
| 2026-04-02 | Ra Capital Management, L.P. | Sell | $18.23 | 260,000 | $4.7M |
| 2025-10-30 | Ra Capital Management, L.P. | Sell | $25.12 | 24,579 | $617,424 |
| 2025-10-29 | Ra Capital Management, L.P. | Sell | $25.22 | 251,518 | $6.3M |
| 2025-10-28 | Ra Capital Management, L.P. | Sell | $27.42 | 124,311 | $3.4M |
| 2025-10-27 | Ra Capital Management, L.P. | Sell | $28.12 | 90,941 | $2.6M |
| 2025-10-24 | Ra Capital Management, L.P. | Sell | $28.01 | 53,345 | $1.5M |
| 2025-10-23 | Ra Capital Management, L.P. | Sell | $28.01 | 76,880 | $2.2M |
| 2025-10-21 | Ra Capital Management, L.P. | Sell | $28.11 | 25,027 | $703,509 |
| 2025-10-21 | Reprogrammed Interchange Llc | Sell | $30.07 | 200 | $6,014 |
| 2025-10-20 | Reprogrammed Interchange Llc | Sell | $30.05 | 11,616 | $349,061 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
VOR shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns VOR
Institutional investors own 86.8% of Vor Biopharma's shares and insiders 9.26%. The largest holder is TCG Crossover Management, LLC with 9.59% of the shares (5.7M), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 5 reduced their stake in the latest filings. Short interest is 15.54% of the float, or 6.11 days of average trading volume. The share count rose 1,517.3% since 2019.
Related: VOR analyst forecast, VOR key metrics. See the VOR stock overview for the latest quote and news.
VOR ownership FAQ
Who owns the most Vor Biopharma stock?
The largest shareholders of Vor Biopharma are TCG Crossover Management, LLC (9.59%), FMR Inc (8.34%), FCPM III SERVICES BV (6.96%), BlackRock Inc (5.86%), VR Adviser, LLC (5.14%).
What percentage of Vor Biopharma is owned by institutions?
Institutions hold 86.8% of Vor Biopharma's shares outstanding; insiders hold 9.26%.
Which funds own Vor Biopharma?
The largest fund holders of Vor Biopharma are Vanguard MStar Total Stk Mkt Idx Invest (2.62%), Fidelity Select Biotechnology (2.37%), Fidelity Small Cap Growth (2.15%), State Street® SPDR® S&P® Biotech ETF (1.86%), iShares Russell 2000 ETF (1.68%).
What is Vor Biopharma's short interest?
7.8M shares of Vor Biopharma were sold short, 15.54% of the float; at the average daily volume it would take 6.11 days to cover.
Are insiders buying or selling Vor Biopharma?
Of the latest 20 reported insider transactions in Vor Biopharma (since October 20, 2025), 0 were purchases and 20 were sales.
How many shares of Vor Biopharma are outstanding?
Vor Biopharma has 54.2M shares outstanding, of which 37.2M are in the public float.